Rebecca A. Clark

The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study

The Lancet Global Health 2025cited by 39position: firstdoi

Effects of reductions in US foreign assistance on HIV, tuberculosis, family planning, and maternal and child health: a modelling study

The Lancet Global Health 2025cited by 25position: middledoi

Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study

The Lancet Global Health 2025cited by 14position: middledoi

Body mass index and tuberculosis risk: an updated systematic literature review and dose–response meta-analysis

International Journal of Epidemiology 2025cited by 9position: middledoi

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials

The Lancet Respiratory Medicine 2025cited by 2position: middledoi

Climate change and tuberculosis: an analytical framework

The Lancet Respiratory Medicine 2025cited by 1position: middledoi

Modelling the effect of a nutritional shock on tuberculosis in India

BMC Global and Public Health 2025cited by 1position: firstdoi

Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: Estimates for South Africa

Vaccine 2024cited by 7position: middledoi

Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report

Frontiers in Tuberculosis 2024cited by 5position: firstdoi

Estimating the Potential Public Health Value of BCG Revaccination

The Journal of Infectious Diseases 2024cited by 4position: firstdoi

The potential impact of new tuberculosis vaccines on the burden of tuberculosis in people with HIV in South Africa

AIDS 2024cited by 1position: middledoi

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study

The Lancet Global Health 2023cited by 57position: firstdoi

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

The Lancet Infectious Diseases 2023cited by 53position: middledoi

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

PLoS Medicine 2023cited by 50position: middledoi

New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

BMC Medicine 2023cited by 30position: firstdoi

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study

PLoS Medicine 2023cited by 27position: middledoi

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries

BMJ Global Health 2023cited by 22position: middledoi

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer

Epidemics 2023cited by 11position: middledoi

Is neglect of self-clearance biasing TB vaccine impact estimates?

BMJ Global Health 2023cited by 1position: middledoi

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

Clinical Infectious Diseases 2022cited by 73position: middledoi

GIGYF1 disruption associates with autism and impaired IGF-1R signaling

Journal of Clinical Investigation 2022cited by 29position: middledoi

New tuberculosis vaccines: advances in clinical development and modelling

Journal of Internal Medicine 2020cited by 50position: middledoi

Recent publications

Grants

Frequent collaborators